SHARE:  
The RNA Transcript, May 9, 2022
News
Jay Querido, University of Michigan RNA Faculty this Fall!

We are thrilled to announce that Jay as agreed to join us as a faculty member in Biological Chemistry, the Center for RNA Biomedicine, and the LSI.
About Dr. Brito Querido:
A native of Cape Verde, Dr. Querido received undergraduate and M.S. degrees at the University of Lisbon. For his Ph.D., Dr. Querido worked with Dr. Yaser Hashem in Strasbourg, France using cryo-EM to study parasite-specific ribosomal proteins. Dr. Querido then moved to Dr. Venki Ramakrishnan’s lab at the MRC Laboratory of Molecular Biology for post-doctoral work, where he has tackled longstanding questions surrounding translation initiation on eukaryotic mRNAs. Most prominently, Dr. Querido determined the structure of a 48S translation initiation complex and suggested a novel mechanism for ribosome recruitment and mRNA scanning (Brito Querido et al., Science 2020).

Future Scientific Plans:
Currently, Dr. Querido is exploring translation initiation on structured mRNAs and the role of the human tumor suppressor protein Pdcd4 in regulating translation. Dr. Querido has exciting plans to continue in this field, with a goal of understanding the many ways in which RNA helicases regulate gene expression in health and disease.

If you would like to reach out to welcome Jay, you may contact him here: jquerido@mrc-lmb.cam.ac.uk
Community
Our U-M RNA Student Postdoc Council hosted it's first in-person RNA Trivia night!

The objective of the RNA council is to work collaboratively across disciplines, build a scientific community, and generate ideas and activities that advance RNA research and education across U-M. The RNA Council is sponsored by The RNA Society.
>> Next event: The RNA Function
Thursday, June 9, 2022
12:00-3:00 PM
BSRB, ABC Seminar rooms
Agenda
12:00 -1:30 Lunch and poster sessions
1:30 - 1:45 Break
1:45 - 3:00 Scientific-Speed-Networking
U-M RNA Innovation Seminar
Unexpected determinants of neuronal identity and properties: the curious cases of PTBP1, PTBP2, and neuronal splicing
Sika Zheng, UC Riverside

TODAY Monday, May 9, 2022
4:00 pm - 5:00 pm
U-M Variations In Biology Seminar Series
Genetics of spectacular diversity in the rock pigeon
Mike Shapiro, University of Utah

Tuesday, May 10, 2022
4:00 pm - 5:00 pm
co-hosted by COPD, MCDB, and EEB
Non-coding RNA Journal Webinar Series
Unexpected Noncoding Roles of RNA in the Regulation of Cancer
Maite Huarte, Cima Universidad de Navarra

Tuesday, May 10, 2022
4:00 pm - 5:00 pm
U-M Oral Dissertation Defense
Associative Learning Circuits Regulate Meal Size Through Dopamine Plasticity
advisor: Monica Dus

Wednesday, May 11, 2022
12:30 - 1:30 PM
U-M LSI Symposium 2022
Viral Pathogens: Us vs. Them

Friday, May 13, 2022
8:45 am - 4:10 pm
Kahn Auditorium, BSRB
U-M Oral Dissertation Defense
mRNA Modifications Modulates Translation Rate and Fidelity
advisors: Kristin Koutmou and Kaushik Ragunathan

Monday, May 16, 2022
9:00 - 10:00 AM
Chemistry 1640
U-M RNA Innovation Seminar
An Academic Approach to Oligonucleotide Therapeutics
Daniel O’Reilly, UMassMed RNA Therapeutics Institute

Monday, May 16, 2022
4:00 pm - 5:00 pm
BSRB, ABC Seminar rooms (livestream)
----Wednesday, May 18, 2022
----10:00 pm - 11:00 am
----Zoom

TRMT112, a master regulator of RNA methyltransferases modifying factors involved in mRNA translation

Fluorescent nanoparticles for amplified detection and imaging of RNA in solution and cells
U-M Department of Molecular, Cellular and Developmental Biology
The Regulation of Signal Transduction by Phase Separated Biomolecular Condensates
Jonathon Ditlev, University of Toronto

Friday, May 20, 2022
12:00 pm - 1:00 pm
1060 BSB
Funding Opportunities

Pfizer is seeking proposals for the advancement of therapeutics in renal disorders
Open for Submissions: April 25th - June 13th, 2022
For more information about the submission process and areas of interest go to pfizercti.com or email: Aileen.Healy@Pfizer.com, Stephen.Berasi@Pfizer.com
Catalyzing translational research efforts by supporting preclinical and commercial clinical development
Innovation Partnerships at the University of Michigan manages Great Lakes Discovery, a ten-year collaboration with Deerfield Management Company, L.P to fund U-M drug discovery from early-stage research to clinical development.

  • Deerfield has committed up to $130 million over the next decade to invest in biomedical research at U-M with the aim of developing potentially life-saving drugs and disease treatments.
  • Projects selected by Great Lakes Discovery will be provided funding and operational support through a development plan aimed at achieving Investigational New Drug (IND) readiness.

GET STARTED WITH A CONSULTATION There is no open Request for Proposal (RFP) - the first step for an interested researcher is to schedule a consultation with the program’s Scientific Collaboration Manager Dr. Seohee You (shyou@umich.edu).

Our members' publications are available through Altmetrics. Queries are currently available: CRISPR, microRNA, molecule, RNA, RNA therapeutics, transcriptome, and translation. Below are recent highlights.
Discovery of a large-scale, cell-state-responsive allosteric switch in the 7SK RNA using DANCE-MaP, S. W. Olson, A. W. Turner, J. W. Arney, I. Saleem, C. A. Weidmann, D. M. Margolis, K. M. Weeks, A. M. Mustoe, (2022) Molecular Cell. 10.1016/j.molcel.2022.02.009

Highlights
  • DANCE-MaP enables complete characterization of RNA structural ensembles in cells
  • The 7SK RNA encodes a large-scale structural switch that modulates P-TEFb binding
  • 7SK structure switches dynamically in response to cell growth and stress
  • The 7SK switch is a potential therapeutic target for modulating transcription

Keywords: DANCE-MaP; ensemble deconvolution; noncoding RNA; transcriptional regulation; cancer; HIV
To share your news and comments, please contact Martina Jerant